ANDA 72112, held by Rising. Clorazepate Dipotassium.
As of Nov 16, 2026, ANDA 72112 (Clorazepate Dipotassium), held by Rising, was first approved by FDA on Aug 26, 1988, with 5 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 26, 1988 | Original application | Approved | None posted |
| Clorazepate Dipotassium15MG · capsule;oral | Clorazepate Dipotassium | Discontinued |
| Clorazepate Dipotassium3.75MG · capsule;oral | Clorazepate Dipotassium | Discontinued |
| Clorazepate Dipotassium7.5MG · capsule;oral | Clorazepate Dipotassium | Discontinued |
| Dec 16, 2016 | Supplement 10Labeling · Standard review | Approved | None posted |
| Mar 9, 2000 | Supplement 5Manufacturing | Approved | None posted |
| Mar 9, 2000 | Supplement 6Manufacturing | Approved | None posted |
| Sep 29, 1999 | Supplement 4Labeling | Approved | None posted |
| Sep 5, 1990 | Supplement 1Labeling | Approved | None posted |
| Aug 26, 1988 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters